Abstract: The present invention relates generally to the field of insulin sensitizers. In particular, the present invention relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of hyperglycemia. The present invention further relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of disorders, conditions, and/or symptoms associated with hyperglycemia in a subject.

Abstract: The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of preterm birth and/or of conditions linked to preterm delivery in a female subject and/or in the offspring. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.

Abstract: The present invention relates to a nutritional composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising at least one N-acetylated oligosaccharide, one galacto-oligosaccharide and one sialylated oligosaccharide for use in preventing and/or treating allergy symptoms in an infant or a young child, by increasing SFCA production, in particular colonic acetate, propionate and/or butyrate, in said infant or young children.

Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in preventing and/or treating allergy symptoms in an infant or a young child, by increasing propionate production, in said infant or young children.

Abstract: The invention discloses a composition comprising oligosaccharide, for use in the prevention and/or treatment of skin conditions and/or skin diseases by increasing SCFA, in particular colonic propionate and butyrate. Said skin disease is in particular atopic dermatitis.

Abstract: The present invention relates to the use in a pregnant or lactating woman of SFCA ingredient, SCFA originating ingredients or mixtures thereof for preventing and/or treating trans epidermal water loss (TEWL) and/or TEWL-associated disorders and/or enhance skin barrier function in the off-spring or breast-fed infant.

Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in reducing and/or controlling food intake in an infant or a young child, and/or for use in promoting a healthy growth in an infant or a young child.

Abstract: The present invention relates to a nutritional composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising at least one N-acetylated oligosaccharide, one galacto-oligosaccharide and one sialylated oligosaccharide for use in preventing and/or treating allergy symptoms in an infant or a young child, by increasing SFCA production, in particular colonic acetate, propionate and/or butyrate, in said infant or young children.

Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide, for use in preventing and/or treating allergy symptoms in an infant or a young child, by increasing propionate production, in said infant or young children.

Abstract: The present invention relates to a nutritional composition comprising an oligosaccharide mixture, said oligosaccharide mixture comprising at least one N-acetylated oligosaccharide, one galacto-oligosaccharide and one sialylated oligosaccharide for use in reducing and/or avoiding excessive fat mass accumulation and/or in preventing any related later in life health disorders in an infant or a young child such as later in life obesity and related comorbidities, by increasing colonic SCFA production and/or GLP-1 secretion/releasein said infant or young child.

Abstract: The present invention relates to the use in a pregnant or lactating woman of SFCA ingredient, SCFA originating ingredients or mixtures thereof for preventing and/or treating trans epidermal water loss (TEWL) and/or TEWL-associated disorders and/or enhance skin barrier function in the off-spring or breast-fed infant.

Abstract: The invention discloses a composition comprising oligosaccharide, for use in the prevention and/or treatmentof skin conditions and/or skin diseases by increasing SCFA, in particular colonic propionate and butyrate. Said skin disease is in particular atopic dermatitis.

Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and at least one N-acetylated oligosaccharide,for use in reducing and/or controlling food intake in an infant or a young child, and/or for use in promoting a healthy growth in an infant or a young child.

Abstract: The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide and atleast one N-acetylated oligosaccharide, for use in reducing and/or avoiding excessive fat mass accumulation in an infant or a young child and/or for use in preventing the related later in life health disorders like later in life obesity and related comorbidities.

Abstract: Microparticulate compositions and nutritional compositions containing the microparticulate compositions are disclosed herein. In a general embodiment, the microparticulate compositions include one or more probiotics and have a size ranging from about micron to about 20 microns. The microparticulate compositions can be added to any suitable nutritional composition.